Related Experiment Videos
Infant random dot stereoacuity cards
Insights
A new random dot stereoacuity test for infants offers a simple, quick method to assess vision development. This test accurately measures stereoacuity in young children, aiding in early detection and management of visual disorders.
Area of Science:
- Ophthalmology
- Developmental Neuroscience
- Pediatric Vision Science
Background:
- Assessing visual sensory outcomes in infants is crucial for managing ophthalmopediatric disorders.
- Existing methods for measuring stereoacuity in infants can be complex or require specialized laboratory settings.
- A simple, portable test is needed for both clinical trials and routine patient management.
Purpose of the Study:
- To develop a straightforward random dot stereoacuity test for infants aged 1.5 to 24 months.
- To evaluate the test's utility in measuring sensory outcomes following treatments for pediatric eye conditions.
- To establish a tool for both clinical trials and everyday clinical practice.
Main Methods:
- Developed random dot stereoacuity test cards with vectographic vertical bar stimuli and crossed disparities.
- Employed a two-alternative, forced-choice, preferential-looking protocol to assess stereoacuity.
- Tested 95 healthy term infants (173 tests) across a 1.5- to 24-month age range, evaluating success rate, validity, and normal performance limits.
Main Results:
- Achieved a high success rate of 91.3% (158/173 tests).
- Observed stereoacuity maturation consistent with prior lab-based studies, with few infants under 2 months showing stereopsis.
- By 12 months, mean stereoacuity was 120 seconds, improving to 56 seconds between 18-24 months. Normal limits ranged from 1000 seconds at 6 months to 100 seconds after 12 months.
Conclusions:
- The developed infant random dot stereoacuity cards provide a simple, rapid, and portable preferential-looking test.
- The test demonstrates a high success rate and strong agreement with established laboratory-based stereoacuity protocols.
- This tool is suitable for assessing infant stereoacuity in clinical and research settings.
Purpose:
The overall goal was to develop a simple test of random dot stereoacuity that can be used during the first 24 months of life to measure sensory outcomes following treatment of ophthalmopediatric disorders, both in the context of clinical trials and in the context of clinical management.
Methods:
A series of random dot stereoacuity test cards were constructed using vectographic vertical bar stimuli with crossed disparities ranging from 1735 to 45 sec. A two-alternative, forced-choice, preferential-looking test protocol was used to measure stereoacuity in 95 healthy term infants (173 tests) over the 1.5-to-24-month age range. Success rate, validity, and tolerance limits for normal performance as a function of age were evaluated.
Results:
The success rate was high (158 of 173 tests; 91.3%). The maturation of random dot stereoacuity was similar to that measured in earlier lab-based preferential-looking and visual evoked potential protocols; few infants younger than 2 months of age demonstrated stereopsis although by 12 months, mean stereoacuity was 2.1 log sec (120 sec). A further improvement to 1.7 log sec (56 sec) was seen during months 18 to 24, consistent with data obtained in an earlier operant random dot protocol. Tolerance limits for normal ranged from approximately 1000 sec at 6 months to 100 sec after 12 months.
Conclusions:
The infant random dot stereoacuity cards provide a simple, quick, and portable preferential-looking test of random dot stereoacuity for infants that has a high success rate and excellent concordance with stereoacuity outcomes from laboratory-based protocols.